scispace - formally typeset
W

Wenyi Wang

Researcher at University of Texas MD Anderson Cancer Center

Publications -  123
Citations -  22012

Wenyi Wang is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Biology. The author has an hindex of 28, co-authored 92 publications receiving 16322 citations. Previous affiliations of Wenyi Wang include Johns Hopkins University & University of Texas Health Science Center at Houston.

Papers
More filters
Journal ArticleDOI

The cancer genome atlas pan-cancer analysis project

John N. Weinstein, +379 more
- 01 Oct 2013 - 
TL;DR: The Pan-Cancer initiative compares the first 12 tumor types profiled by TCGA with a major opportunity to develop an integrated picture of commonalities, differences and emergent themes across tumor lineages.
Journal Article

The Cancer Genome Atlas Pan-Cancer analysis project

Kyle Chang, +337 more
- 01 Sep 2013 - 
TL;DR: The Cancer Genome Atlas (TCGA) Research Network has profiled and analyzed large numbers of human tumors to discover molecular aberrations at the DNA, RNA, protein and epigenetic levels as mentioned in this paper.
Journal ArticleDOI

Comprehensive molecular characterization of urothelial bladder carcinoma

John N. Weinstein, +296 more
- 01 Jan 2014 - 
TL;DR: Ch Chromatin regulatory genes were more frequently mutated in urothelial carcinoma than in any other common cancer studied so far, indicating the future possibility of targeted therapy for chromatin abnormalities.
Journal ArticleDOI

The Molecular Taxonomy of Primary Prostate Cancer

Adam Abeshouse, +311 more
- 05 Nov 2015 - 
TL;DR: The Cancer Genome Atlas (TCGA) has been used for a comprehensive molecular analysis of primary prostate carcinomas as discussed by the authors, revealing substantial heterogeneity among primary prostate cancers, evident in the spectrum of molecular abnormalities and its variable clinical course.

The Molecular Taxonomy of Primary Prostate Cancer

Adam Abeshouse, +309 more
TL;DR: A comprehensive molecular analysis of 333 primary prostate carcinomas revealed a molecular taxonomy in which 74% of these tumors fell into one of seven subtypes defined by specific gene fusions (ERG, ETV1/4, and FLI1) or mutations (SPOP, FOXA1, and IDH1).